Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 62332-156

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 62332-156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pramipexole 0 375 mg

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.375 mg oral tablets. The label indicates a 30 tablet count bottle, with dosing instructions for once daily use. Manufactured by Alembic Pharmaceuticals Inc., the label includes storage instructions and regulatory details such as NDC 62332-154-30 and manufacturing location in India for Alembic Pharmaceuticals.*

FDA Label Image

Pramipexole 0 75 mg

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.75 mg, oral tablets in a 30-tablet package by Alembic Pharmaceuticals Inc. The label includes dosage strength, instructions to take once daily, storage conditions, and dispensing information with Rx only status.*

FDA Label Image

Pramipexole 1 5 mg

Pramipexole Dihydrochloride 1.5 mg Extended-Release Tablets label showing dosage strength and form. The label indicates the product contains 30 tablets for oral use, with instructions for pharmacist dispensing and storage. Manufactured by Alembic Pharmaceuticals Inc., the label includes the NDC code 62332-156-30 and emphasizes that tablets must be swallowed whole.*

FDA Label Image

Pramipexole 3 75 mg

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3.75 mg, oral tablet dosage form. The label indicates a 30-tablet count and specifies once daily use. It includes manufacturer details for Alembic Pharmaceuticals Inc. and storage instructions. The label also features NDC 62332-160-30 and dispensing instructions for pharmacists.*

FDA Label Image

Pramipexole 3 mg

Pramipexole Dihydrochloride Extended-Release Tablets 3 mg, oral tablet, once daily dosing. The label shows a white background with text including the NDC number 62332-158-30 and indicates the product is manufactured by Alembic Pharmaceuticals Inc. The package contains 30 tablets. Additional storage information and dosage instructions are provided on the label.*

FDA Label Image

Pramipexole 4 5 mg

Label for Pramipexole Dihydrochloride Extended-Release Tablets 4.5 mg, oral tablets supplied in a container of 30 tablets. The label includes dosing instructions, storage conditions, and manufacturer details from Alembic Pharmaceuticals Inc. It specifies the prescription-only status and features branding with the Alembic logo and NDC 62332-159-30.*

FDA Label Image

Structure (Pramipexole Structure)

Chemical structure diagram of pramipexole dihydrochloride showing its molecular arrangement including rings and functional groups, annotated with two hydrochloride (HCl) and one water (H2O) molecules.*

FDA Label Image

Premipexole 2 25 mg

Pramipexole Dihydrochloride Extended-Release Tablets label showing 2.25 mg strength in oral tablet form. The label includes dosing instructions for once daily use and packaging information for 30 tablets. Manufactured by Alembic Pharmaceuticals Inc., the label also provides storage instructions and cautions for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.